• Khalid Mahmood Qureshi
  • Raja Zafar Ahmed
  • Ijazul Haq Taseer
  • Misbahul Islam Khan
  • Nusrat Pasha


The purpose of this study was to evaluate the effect of Lisinopril on microalbuminuria in non- insulin dependentdiabetic hypertensive patients. One hundred and twenty patients were divided into two groups. Croup-A was givenplacebo of Lisinopril and Group-B was given Lisinopril in a fixed dose of 10 mg once daily for two weeks. Comparisonof microalbuminuria before and after the treatment showed a decrease in microalbuminuria level in patients treatedwith Lisinopril.


I Philip R. How to treat hypertension in diabetic

patients? Postgraduate Med Hypertens Diabetes 1987;

(2): 213-32.

Viberti GC. 1 Hill RD. Jarret RJ and Keen 11.

Microalbuminuria as a predictor of clinical

nephropathy in insulin dependent diabetes mellitus.

Lancet 1982; 1 1430.

Crepaldi G. Carraro A. Broccoe et al. Hypertension and

noninsulin dependent diabetes. A comparison between

an angiotension converting enzyme inhibitor and a

calcium antagonist. Acta Diabetol 1995; 32(3): 203-8.

Brenner BM. Meyer TW and Hostetler TH. Dietary

protein intake and the progressive nature of kidney

disease. N. F.ng .1 Med 1982. 307: 652.

Hostetter Th. Rennke HG and Brenner BMV The case

for internal hypertension in the initiation and

progression diabetic and other glomerulopathies. Am .1

Med 1982:72 375.

Remuzzi A. Benigni A. Malanchini B et al. ACL

inhibition prevents renal failure and death in

uninephrectomized MWF/Ztn rats. Kidney Int. 1995;

(5): 1319-26.

Barkis GL, Copley JB. Vicknair N et al. Calcium

channel blockers versus other antihypertensive therapy

on progression of NIDDM associated nephropathy.

Kidney Int. 1996: 50(5): 1641-50.

Agardh CP. Garcia P.l. Charbannel B et al. Greater

reduction of urinary albumin excretion in hypertensive

type-11 diabetic patients with incipient nephropathy by

Lisinopril than by nifedipine .1 Human Hypertens

; 10(3): 185-92.